Explore Stanford technologies available for licensing:

Stanford researchers have developed a metal water jet nozzle that enables laser-generated MeV ion beams. When paired with a laser system, the technology could enable more compact, cost-effective medical isotope production and other ion-beam applications.

Researchers at Stanford have developed a three-dimensional human joint organoid platform designed to more accurately model joint tissue biology for musculoskeletal diseases, including osteoarthritis and osteonecrosis.

Researchers at Stanford have developed a blood test technology that detects multiple types of cancer signals at once, using a single, streamlined workflow.

Stanford scientists have developed CardioGuardian, a method that uses cell-free RNA from a routine blood draw to estimate an individual's inherited risk of cardiovascular disease, capturing heritable risk that conventional DNA-based approaches miss.

Stanford researchers have developed a non-invasive seismic sensing method to monitor groundwater and subsurface pressure changes at multiple depths using passive ground vibration data.

Stanford scientists have developed CSF-Seq, a whole-transcriptome sequencing platform that reads cell-free RNA in cerebrospinal fluid to enable minimally invasive molecular profiling of neurological and neuro-oncologic disease, including leptomeningeal disease.

Large-scale, granular biological datasets such as proteomic, metabolomic, and transcriptomic profiles are powering the current shift toward precision medicine.

Metastatic castration resistant prostate cancer (mCRPC) is an advanced stage of prostate cancer managed with a combination of various therapeutics.

Stanford scientists have developed a platform to engineer hematopoietic stem cells (HSCs) to express a genetic payload in specific cell lineages.

Stanford researchers have discovered programmable mechanisms to mobilize T and Natural Killer (NK) cells to solid tumors.

Researchers at Stanford have developed Electro-LEV, a microfluidic platform that uses programmable electromagnets to levitate and sort cells by their physical properties — with no fluorescent labels or antibodies required.

Over 1.3 million hip and knee replacements are performed in the US annually.

Malignant tumor cells shed their DNA into the bloodstream of breast cancer patients in the form of cell-free DNA (cfDNA) and can be assayed to identify cancer-associated biomarkers.

Researchers at Stanford have developed Elastic Rod Origami (RodOri), a new class of mechanical structures that can be physically reconfigured into many different shapes, each with distinct and precisely controlled mechanical properties.

Stanford researchers have developed an innovative biomimetic cardiac sleeve designed to provide passive external mechanical support to the heart while mimicking the natural motion and mechanical behavior of healthy ventricular tissue.